Meeting Report: 2023 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Therapy of Neuromuscular Diseases’
Journal of Neuromuscular Diseases · 2024
DOI: 10.3233/jnd-240002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuromuscular Diseases, 2024. Verfasst von Angela Lek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Muscular Dystrophy Association, Chicago, IL, USA. Hauptthemen laut MEDLINE: Genetic Therapy, Neuromuscular Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This meeting report summarizes the presentations and discussions held at the summit on Challenges in Gene Therapy hosted by the Muscular Dystrophy Association (MDA) in 2023. Topics covered include safety issues, mitigation strategies and practical considerations pertaining to the clinical translation of gene therapies for neuromuscular disease. The listing of actionable recommendations will assist in overall efforts in the field to achieve safe and efficacious translation of gene therapies for neuromuscular disease patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Muscular Dystrophy Association, Chicago, IL, USA.
- Section of Allergy and Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA.
- Department of Pediatrics and Powell Gene Therapy Center, University of Florida, Gainesville, FL, USA.
- Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Zitieren
APA
Lek, A., Atas, E., Lin, B., Hesterlee, S. E., Abbott, J. K., Byrne, B. J., & Bönnemann, C. G. (2024). Meeting Report: 2023 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Therapy of Neuromuscular Diseases’. Journal of Neuromuscular Diseases. https://doi.org/10.3233/jnd-240002
Vancouver
Lek A, Atas E, Lin B, Hesterlee SE, Abbott JK, Byrne BJ, et al. Meeting Report: 2023 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Therapy of Neuromuscular Diseases’. Journal of Neuromuscular Diseases. 2024. doi:10.3233/jnd-240002
BibTeX
@article{Lek2024,
author = {Lek, Angela and Atas, Evrim and Lin, Brian and Hesterlee, Sharon E and Abbott, Jordan K and Byrne, Barry J and Bönnemann, Carsten G},
title = {Meeting Report: 2023 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Therapy of Neuromuscular Diseases’},
journal = {Journal of Neuromuscular Diseases},
year = {2024},
doi = {10.3233/jnd-240002}
}
EUVIMED